File Download
Patent History
- ApplicationPC T/US2007010041 2007-04-25
- PublicationWO 2007142757 2007-12-13
Patent Family
- EP 2150268 (A1) 2010-02-10
- EP 2581097 (A1) 2013-04-17
- CA 2722465 (A1) 2008-11-06
- JP 2009535338 (A) 2009-10-01
- CA 2650230 (A1) 2007-12-13
- EP 2012842 (A2) 2009-01-14
- KR 20090015935 (A) 2009-02-12
- KR 20110091019 (A) 2011-08-10
- US 2008032934 (A1) 2008-02-07
- US 2008091233 (A1) 2008-04-17
- WO 2008134544 (A1) 2008-11-06
- AU 2007257425 (A1) 2007-12-13
- CN 101472620 (A) 2009-07-01
- JP 2010526779 (A) 2010-08-05
Supplementary
-
Citations:
- Appears in Collections:
granted patent: COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS
Title | COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS |
---|---|
Priority Date | 2006-04-25 US 11/745601P |
Inventors | |
Issue Date | 2007 |
Citation | WO Patent WO 2007142757. World Intellectual Property Organization (WIPO), PatentScope, 2007 How to Cite? |
Abstract | Compositions which self-assemble under physiological conditions are formulate for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may als include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer.; The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatme such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination wit an oil and forms a laminate.; In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent. |
Persistent Identifier | http://hdl.handle.net/10722/210490 |
References |
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2015-06-17T07:02:36Z | - |
dc.date.available | 2015-06-17T07:02:36Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | WO Patent WO 2007142757. World Intellectual Property Organization (WIPO), PatentScope, 2007 | - |
dc.identifier.uri | http://hdl.handle.net/10722/210490 | - |
dc.description.abstract | Compositions which self-assemble under physiological conditions are formulate for application to wounds. The formulations include a pharmaceutically acceptable carrier or are provided as part of a medical device or coating. The formulations may als include other therapeutic, prophylactic or diagnostic agents. The formulation can be administered as appropriate for treatment of one or more disorders or conditions. For example, the formulation may be applied to repair an injury or during surgery of the lung, eye or dura, or following an epidural or spinal tap, to stop leakage of blood, interstitial fluid, or cerebrospinal fluid. The formulation may be administered to a burn or ulcer.; The formulation may be dispersed in a suture or adhesive for administration at the time of or as released following suturing or gluing of a wound, thereby limiting bleeding, loss of tissue fluids, or other fluids such as those produced by parenchymal tissues such as the liver, pancreas, and gastrointestinal tract. The formulation may be applied to any site of bleeding, in a bandage, gauze, sponge, or other material, for immediate control of bleeding, or released later to control bleeding if the initial treatme such as suturing or pressure is insufficient. In one embodiment, the formulation is provided as a dry or lyophilized powder. In another embodiment, the material is provided in water. In another embodiment, the material is provided in combination wit an oil and forms a laminate.; In another embodiment, the formulation is provided as a coating on a device, for example a stent or a catheter. The material is also useful to isolate tissue, for preservation of tissue for subsequent transplantation or reattachment, and as a bulking, stabilizing or hydrating agent. | - |
dc.relation.isreferencedby | WO 2013123491 (A1) 2013-08-22 | - |
dc.relation.isreferencedby | WO 2015035189 (A1) 2015-03-12 | - |
dc.relation.isreferencedby | WO 2015027203 (A1) 2015-02-26 | - |
dc.relation.isreferencedby | EP 2581097 (A1) 2013-04-17 | - |
dc.relation.isreferencedby | WO 2008134544 (A1) 2008-11-06 | - |
dc.title | COMPOSITIONS AND METHODS FOR AFFECTING MOVEMENT OF CONTAMINANTS, BODILY FLUIDS OR OTHER ENTITIES AND/OR AFFECTING OTHER PHYSIOLOGICAL CONDITIONS | - |
dc.type | Patent | - |
dc.identifier.authority | SO, KWOK-FAI=rp00329 | - |
dc.identifier.authority | LIANG, YU-XIANG=rp00510 | - |
dc.identifier.authority | TAY, DAVID=rp00336 | - |
dc.description.nature | published_or_final_version | - |
dc.contributor.inventor | ELLIS-BEHNKE, RUTLEDGE | - |
dc.contributor.inventor | LIANG, YU-XIANG | - |
dc.contributor.inventor | SCHNEIDER, GERALD E | - |
dc.contributor.inventor | SO, KWOK-FAI | - |
dc.contributor.inventor | TAY, DAVID | - |
patents.identifier.application | PC T/US2007010041 | - |
patents.description.assignee | MASSACHUSETTS INST TECHNOLOGY [US]; ELLIS-BEHNKE RUTLEDGE [US]; LIANG YU-XIANG [CN]; SCHNEIDER GERALD E [US]; SO KWOK-FAI [CN]; TAY DAVID [CN] | - |
patents.description.country | World Intellectual Property Organization (WIPO) | - |
patents.date.publication | 2007-12-13 | - |
dc.relation.references | US 2006025524 (A1) 2006-02-02 | - |
dc.relation.references | WO 9509659 (A1) 1995-04-13 | - |
dc.relation.references | XP 002398333 | - |
dc.relation.references | W O03084980 (A3) 2003-12-11 | - |
dc.relation.references | WO 03084980 (A2) 2003-10-16 | - |
dc.relation.references | U S7884185 (B2) 2011-02-08 | - |
patents.identifier.hkutechid | Anat-2006-00186A-2 | - |
patents.date.application | 2007-04-25 | - |
patents.date.priority | 2006-04-25 US 11/745601P | - |
patents.description.cc | wo | - |
patents.identifier.publication | WO 2007142757 | - |
patents.relation.family | EP 2150268 (A1) 2010-02-10 | - |
patents.relation.family | EP 2581097 (A1) 2013-04-17 | - |
patents.relation.family | CA 2722465 (A1) 2008-11-06 | - |
patents.relation.family | JP 2009535338 (A) 2009-10-01 | - |
patents.relation.family | CA 2650230 (A1) 2007-12-13 | - |
patents.relation.family | EP 2012842 (A2) 2009-01-14 | - |
patents.relation.family | KR 20090015935 (A) 2009-02-12 | - |
patents.relation.family | KR 20110091019 (A) 2011-08-10 | - |
patents.relation.family | US 2008032934 (A1) 2008-02-07 | - |
patents.relation.family | US 2008091233 (A1) 2008-04-17 | - |
patents.relation.family | WO 2008134544 (A1) 2008-11-06 | - |
patents.relation.family | AU 2007257425 (A1) 2007-12-13 | - |
patents.relation.family | CN 101472620 (A) 2009-07-01 | - |
patents.relation.family | JP 2010526779 (A) 2010-08-05 | - |
patents.description.kind | A2 | - |
patents.type | Patent_granted | - |